Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Injection for Lymphocele Prevention in Prostatectomy
NCT06258486Phase 4Not yet recruiting
- Sponsor
- Kaiser Permanente
- Start
- Feb 2024
- Primary completion
- Feb 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of indocyanine green in lymphocele, sponsored by Kaiser Permanente. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
indocyanine green
03
Conditions
lymphocele
Beyond the preview
Go deeper on NCT06258486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06258486.